GlassScriptPhysician profile
Deanna Rosenberg
NPI 1568023646
$5,838.93
in general payments reported to CMS, 2019-2025
25 companies · $1,027 in 2025
The $1,027 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $548 · 2022: $1,336 · 2023: $1,541 · 2024: $1,388 · 2025: $1,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,875 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,874.65 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $896.00 | 2021-2025 | |
| Abbvie INC. | $804.61 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $672.50 | 2021-2025 | Dupixent |
| Ucb, INC. | $488.04 | 2023-2025 | Bimzelx, Cimzia |
| Janssen Biotech, INC. | $463.29 | 2022-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $325.06 | 2021-2025 | Winlevi |
| Incyte Corporation | $320.36 | 2021-2025 | Opzelura, Opzelura |
| Mayne Pharma Commercial LLC | $247.81 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $233.12 | 2021-2025 | |
| Galderma Laboratories, L.P. | $227.09 | 2021-2025 | |
| Lilly USA, LLC | $199.42 | 2021-2024 | Taltz, Ebglyss, Olumiant |
| Leo Pharma INC. | $181.59 | 2022-2025 | Adbry |
| Journey Medical Corporation | $161.05 | 2022-2025 | |
| Pfizer INC. | $147.07 | 2022-2024 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $74.78 | 2023-2024 | Vtama |
| Organon LLC | $74.33 | 2025 | Vtama |
| Amgen INC. | $54.27 | 2025 | Otezla |
| Arcutis Biotherapeutics, INC. | $45.17 | 2024-2025 | Zoryve |
| Epi Health, LLC | $32.86 | 2021-2022 | |
| Sanofi Pasteur INC. | $31.41 | 2024 | |
| Vyne Pharmaceuticals INC. | $30.39 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.92 | 2023 | Jublia, Duobrii, Arazlo |
| Strata Skin Sciences, INC. | $13.94 | 2025 | Xtrac |
| E.R. Squibb & Sons, L.L.C. | $13.86 | 2023 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deanna Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.